SKAN Research Trust United States of America United Kingdom England

SKAN, the Wellcome Sanger Institute and University of Newcastle to study early stem cell mutations in rare blood disorder

is a Bengaluru-based not-for-profit medical research trust that leverages transformational technologies to develop new therapies for ageing and neurological ailments, cardiovascular diseases, diabetes remission and lifestyle related disorders. SKAN applies its expertise in gut microbiome, genomics, stem cells, molecular biology, biomarkers, immunotherapies, nutrition, and alternate therapies to uncover kinder and gentler treatment protocols for ailments. Bioinformatics at SKAN vigorously pursues cutting edge artificial intelligence, machine learning and other advanced technologies to predict, pre-empt, diagnose, treat, and facilitate remission of medical disorders. The Mission statement of SKAN is "Transform the future of medicine. Impacting millions of lives".

Media contact: [e-mail]

Careers: [e-mail]

About Wellcome Sanger Institute

Founded to sequence the human genome, the Sanger Institute is a biomedical research centre recognized globally for undertaking large scale genome science that forms the foundations of knowledge in biology and medicine. In order to deliver on its mission to "apply and explore genomic technologies at scale to advance the understanding of biology and improve health", the Sanger Institute is committed to collaborating, leading, convening, engaging globally and providing world-class training to scientists and specialists in genomic research. The Sanger Institute strategically deploys its Wellcome core funding to enable faculty-driven genomic science, making discoveries not easily made elsewhere.

About University of Newcastle

As a member of the Russell Group, an association of 24 research-intensive institutions in the UK, Newcastle is delivering pioneering research that makes a positive impact in the world. From reversing Type 2 diabetes to protecting cultural property, Newcastle researchers are tackling international challenges to improve lives and influence policy around the world. Newcastle has one of the largest European Union research portfolios in the UK.

Photo: https://mma.prnewswire.com/media/2447397/SKAN_theWellcomeSangerInstitute_UniversityofNewcastle.jpg
Logo: https://mma.prnewswire.com/media/2082007/4257624/SKAN_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/skan-the-wellcome-sanger-institute-and-university-of-newcastle-to-study-early-stem-cell-mutations-in-rare-blood-disorder-302181490.html